Sonefpeglutide

N/A

Report date: 2024/12/25 14:07:15

Base Information

Drug NameSonefpeglutide
Drug Alias NameLAPS-GLP-2 analogHM-15910HM-15912
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsRenal InsufficiencyShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyShort Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A